RNA tertiary structure mediation by adenosine platforms

Science

Volumn 273, Issue 5282, 1996, Pages 1696-1699

  Cate, Jamie H ^a   Gooding, Anne R ^b   Podell, Elaine ^b   Zhou, Kaihong ^a   Golden, Barbara L ^b   Szewczak, Alexander A ^b   Kundrot, Craig E ^b   Cech, Thomas R ^b   Doudna, Jennifer A ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASE PAIRING; CHEMICAL MODIFICATION; CRYSTAL STRUCTURE; DNA HELIX; INTRON; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TERTIARY STRUCTURE; RNA STRUCTURE; SEQUENCE HOMOLOGY;

EID: 0029796982     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.273.5282.1696     Document Type: Article

References (29)

1. F. Michel and E. Westhof, J. Mol. Biol. 216, 585 (1990).
2. M. Costa and F. Michel, EMBO J. 14, 1276 (1995).
3. L. Jaeger, E. Westhof, F. Michel, J. Mol. Biol. 221, 1153 (1991).
4. M. E. Harris et al., EMBO J. 13, 3953 (1994).
5. F. L. Murphy and T. R. Cech, J. Mol. Biol. 236, 49 (1994).
6. H. Pley, K. Flaherty, D. McKay, Nature 372, 111 (1994).
7. J. H. Cate et al., Science 273, 1678 (1996).
8. C. R. Woese, S. Winker, R. R. Guteil, Proc. Natl. Acad. Sci. U.S.A. 87, 8467 (1990).
9. The N3 of the 5′ adenosine is 2.8 to 3.4 Å from the N6 of the 3′ adenosine in the platform; coordinate error in the current model is approximately 0.4 Å, determined according to P. V. Luzzati [Acta Crystallogr. 5, 802 (1955)].
10. K. Shetty and S. A. Strobel, unpublished data.
11. In the two platforms in internal loops (J6/6a and J6a/ 6b), the 5′-A pucker is O4′-endo, C1′-exo; in L5c the 5′-A of the platform has C3′-exo sugar pucker. Canonical A-form helices have C3′-endo ribose puckers; W. Saenger, Principles of Nucleic Acid Structure (Springer-Verlag, New York, 1984), pp. 55-68.
12. C electron density map is consistent with a metal ion or water molecule in the major groove coordinated to the ribose and phosphate of the 5′ A and 3′ A of the platform, respectively, and to N7 and 06 of the G in the G·U wobble below the motif. In the L5c loop platform, however, there is density for a putative magnesium ion coordinated to phosphates of the 3′ A of the platform and the adjacent A of the A·U noncanonical pair. Both molecules in the asymmetric unit reflect these differences between the platforms.
13. J. A. Doudna and T. R. Cech, RNA 1, 36 (1995).
14. 1 in side-by-side experiments. Preliminary RNA splicing analysis of a precursor RNA with a two-base change in the third adenosine platform, A171-A172 to U-U, showed a twofold reduction in activity at low magnesium ion concentration (5 mM) and even less of an effect at higher magnesium concentrations. One example each of potential C-U and U-C platforms occurs in the tetraloop receptor motif of group I introns in subclasses IC1 and IC3.
15. S. Couture et al., J. Mol. Biol. 215, 345 (1990).
16. B. Laggerbauer, F. L. Murphy, T. R. Cech, EMBO J. 13, 2669 (1994).
17. F. L. Murphy and T. R. Cech, Biochemistry 32, 5291 (1993).
18. In the internal-loop A platforms, the 3′ A is always susceptible to methylation. In the L5c platform, the 3′ A is protected only in the intact intron.
19. The solvent accessible surface of the molecule was determined with a probe of radius 2.0 for adenosine modification Å, the "effective" radius of dimethyl sulfate determined by the method of S. R. Holbrook and S.-H. Kim [Biopolymers 22, 1145 (1983)].
20. J. D. Puglisi, R. Tan, B. J. Calnan, A. D. Frankel, J. R. Williamson. Science 257, 76 (1992); F. Aboul-ela, J. Kam, G. Varani, J. Mol. Biol. 253, 313 (1995); Y. Yang, M. Kochoyan, P. Burgstaller, E. Westhof, M. Famulok, Science 272, 1343 (1996); F. Jiang, R. A. Kumar, R. A. Jones, D. J. Patel, Nature 382, 171 (1996); T. Dieckmann, E. Suzuki, G. K. Nakamura, J. Feigon, RNA, in press.
21. J. D. Puglisi, R. Tan, B. J. Calnan, A. D. Frankel, J. R. Williamson. Science 257, 76 (1992); F. Aboul-ela, J. Kam, G. Varani, J. Mol. Biol. 253, 313 (1995); Y. Yang, M. Kochoyan, P. Burgstaller, E. Westhof, M. Famulok, Science 272, 1343 (1996); F. Jiang, R. A. Kumar, R. A. Jones, D. J. Patel, Nature 382, 171 (1996); T. Dieckmann, E. Suzuki, G. K. Nakamura, J. Feigon, RNA, in press.
22. J. D. Puglisi, R. Tan, B. J. Calnan, A. D. Frankel, J. R. Williamson. Science 257, 76 (1992); F. Aboul-ela, J. Kam, G. Varani, J. Mol. Biol. 253, 313 (1995); Y. Yang, M. Kochoyan, P. Burgstaller, E. Westhof, M. Famulok, Science 272, 1343 (1996); F. Jiang, R. A. Kumar, R. A. Jones, D. J. Patel, Nature 382, 171 (1996); T. Dieckmann, E. Suzuki, G. K. Nakamura, J. Feigon, RNA, in press.
23. J. D. Puglisi, R. Tan, B. J. Calnan, A. D. Frankel, J. R. Williamson. Science 257, 76 (1992); F. Aboul-ela, J. Kam, G. Varani, J. Mol. Biol. 253, 313 (1995); Y. Yang, M. Kochoyan, P. Burgstaller, E. Westhof, M. Famulok, Science 272, 1343 (1996); F. Jiang, R. A. Kumar, R. A. Jones, D. J. Patel, Nature 382, 171 (1996); T. Dieckmann, E. Suzuki, G. K. Nakamura, J. Feigon, RNA, in press.
24. J. D. Puglisi, R. Tan, B. J. Calnan, A. D. Frankel, J. R. Williamson. Science 257, 76 (1992); F. Aboul-ela, J. Kam, G. Varani, J. Mol. Biol. 253, 313 (1995); Y. Yang, M. Kochoyan, P. Burgstaller, E. Westhof, M. Famulok, Science 272, 1343 (1996); F. Jiang, R. A. Kumar, R. A. Jones, D. J. Patel, Nature 382, 171 (1996); T. Dieckmann, E. Suzuki, G. K. Nakamura, J. Feigon, RNA, in press.
25. S. H. Damberger and R. R. Gutell, Nucleic Acids Res. 22, 3508 (1994).
26. Mutation of the J5a/6b platform in P4-P6 from A-A to G-A produced a P4-P6 derivative that appeared to fold correctly in solution (5), but the RNA was not tested for activity.
27. D. Moazed and H. F. Noller, Cell 47, 985 (1986).
28. M. Carson, J. Appl. Cryst. 24, 958 (1991).
29. We thank K. Blount, D. Sheehan, and A. Zaug for functional assays; F. Michel, P. Moore, and A. M. Pyle for helpful discussions; and A. Ferré-d'Amaré, S. Strobel, and T. Griffin for review of the manuscript. This work was funded by the Lucille P. Markey Charitable Trust, the Donaghue Medical Research Foundation and NIH grant GM22778-21 (J.A.D.), NIH training grant 5T32GM08283-07 (J.H.C.), American Cancer Society postdoctoral fellowship (B.L.G.), NSF grant MCB-9221307 (C.E.K.), Howard Hughes Medical Institute (T.R.C.), and the Keck Foundation (C.E.K. and T.R.C.); T.R.C. is a Howard Hughes Medical Institute Investigator; J.A.D. is a Lucille P. Markey Scholar in Biomedical Science, a Young Investigator of the Donaghue Medical Research Foundation, a Searle Scholar, and a Beckman Young Investigator.